CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8+ T cells.
Wang C, Zheng P, Wang A, Fan X, Li T, Hong J, Wang R, Zhang C, Luo C, Yang W, Gao D, Salai A, Luo M, Lu Z, Li D, Lin M, Peng J, Li G, Han S, Zhao Y.
Wang C, et al. Among authors: li t, li d, li g.
Nat Cancer. 2026 May 15. doi: 10.1038/s43018-026-01169-4. Online ahead of print.
Nat Cancer. 2026.
PMID: 42141174